Integrating transcription factor binding site information with gene expression datasets

Bioinformatics

Volumn 23, Issue 3, 2007, Pages 298-305

  Jeffery, Ian B ^a   Madden, Stephen F ^a   McGettigan, Paul A ^a   Perrière, Guy ^b   Culhane, Aedín C ^c   Higgins, Desmond G ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITÉ LYON 1   (France)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BENIGN TUMOR; BINDING SITE; BIOINFORMATICS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRESPONDENCE ANALYSIS; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN MOTIF; TISSUE DISTRIBUTION;

EID: 33847312362     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btl597     Document Type: Article

References (55)

1. Aerts,S. et al. (2003) Toucan: Deciphering the cis-regulatory logic of coregulated genes. Nucleic Acids Res., 31, 1753-1764.
2. Bailey,T.L. and Elkan,C. (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol., 2, 28-36.
3. Benson,R.C.,Jr et al. (1985) Androgen receptor binding activity in human prostate cancer. Cancer, 55, 382-388.
4. Benzécri,J. (1976) L'Analyse de Donne'es. II. L'Analyse des Correspondances. Dunod, Paris.
5. Bhalla,A.K. et al. (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab., 57, 1308-1310.
6. Bredel,M. et al. (2005) High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res., 65, 4088-4096.
7. Breitling,R. et al. (2004) Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett., 573, 83-92.
8. Breitling,R. and Herzyk,P. (2005) Rank-based methods as a non-parametric alternative of the T-statistic for the analysis of biological microarray data. J. Bioinform. Comput. Biol., 3, 1171-1189.
9. Buttyan,R. et al. (1987) Enhanced expression of the c-myc protooncogene in highgrade human prostate cancers. Prostate, 11, 327-337.
10. Chalepakis,G. et al. (1993) Pax: Gene regulators in the developing nervous system. J. Neurobiol., 24, 1367-1384.
11. Chang,J. et al. (2003) Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation, 108, 407-413.
12. Chen,N. et al. (2006) Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis. Oncogene, 25, 579-587.
13. Culhane,A.C. et al. (2002) Between-group analysis of microarray data. Bioinformatics, 18, 1600-1608.
14. Culhane,A.C. et al. (2003) Cross-platform comparison and visualisation of gene expression data using co-inertia analysis. BMC Bioinformatics, 4, 59.
15. Culhane,A.C. et al. (2005) MADE4: An R package for multivariate analysis of gene expression data. Bioinformatics, 21, 2789-2790.
16. Dilaver,G. et al. (2003) Colocalisation of the protein tyrosine phosphatases PTP-SL and PTPBR7 with beta4-adaptin in neuronal cells. Histochem. Cell Biol., 119, 1-13.
17. Dolédec,S. and Chessel,D. (1987) Rhythmes saisonniers et composantes stationelles en milieu aquatique I - Description d'un plan d'observations complet par projection de variables. Acta Oecologica Oecologica Generalis, 8, 403-426.
18. Dolédec,S. and Chessel,D. (1994) Co-inertia analysis: An alternative method for studying species-environment re-lationships. Freshw. Biol., 31, 277-294.
19. Du,Z. et al. (2003) Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue. Chin. Med. J. (Engl.), 116, 1936-1939.
20. Elnitski,L. et al. (2002) PipTools: A computational toolkit to annotate and analyze pairwise comparisons of genomic sequences. Genomics, 80, 681-690.
21. Fellenberg,K. et al. (2001) Correspondence analysis applied to microarray data. Proc. Natl Acad. Sci. USA, 98, 10781-10786.
22. Foster,C.S. et al. (2004) Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene, 23, 5871-5879.
23. Fukuchi,J. et al. (2004) Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res., 64, 7686-7689.
24. Fukuda,S. et al. (2002) Characterization of the biological functions of a transcription factor, c-myc intron binding protein 1 (MIBP1). J. Biochem. (Tokyo), 131, 349-357.
25. Goswami,S.K. et al. (1993) MyoD transactivates angiotensinogen promoter in fibroblast C3H10T1/2 cells. Cell. Mol. Biol. Res., 39, 125-130.
26. Gunther,S. et al. (2004) VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation. Nucleic Acids Res., 32, 791-802.
27. Ho Sui,S.J. et al. (2005) oPOSSUM: Identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res., 33, 3154-3164.
28. Höskuldsson,A. (1988) PLS regression methods. J. Chemomet., 2, 211-228.
29. Irizarry,R.A. et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
30. Kaplan,J. and Calame,K. (1997) The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression. Nucleic Acids Res., 25, 1108-1116.
31. Karanam,S. and Moreno,C.S. (2004) CONFAC: Automated application of comparative genomic promoter analysis to DNA microarray datasets. Nucleic Acids Res., 32, W475-W484.
32. Kashani,M. et al. (1998) Expression of the aryl hydrocarbon receptor (AhR) and the aryl hydrocarbon receptor nuclear translocator (ARNT) in fetal, benign hyperplastic, and malignant prostate. Prostate, 37, 98-108.
33. Lawrence,C.E. et al. (1993) Detecting subtle sequence signals: A Gibbs sampling strategy for multiple alignment. Science, 262, 208-214.
34. Ma,K. et al. (2006) The transcription factor regulatory factor X1 increases the expression of neuronal glutamate transporter type 3. J. Biol. Chem., 281, 21250-21255.
35. Myslinski,E. et al. (1998) ZNF76 and ZNF143 are two human homologs of the transcriptional activator Staf. J. Biol. Chem., 273, 21998-22006.
36. Palayoor,S.T. et al. (1999) Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene, 18, 7389-7394.
37. Pollock,R. and Treisman,R. (1991) Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev., 5, 2327-2341.
38. Ramanan,N. et al. (2005) SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability. Nat. Neurosci., 8, 759-767.
39. Regnauld,K. et al. (2002) G-protein alpha(olf) subunit promotes cellular invasion, survival, and neuroendocrine differentiation in digestive and urogenital epithelial cells. Oncogene, 21, 4020-4031.
40. Roberts,V.J., van Dijk,M.A. and Murre,C. (1995) Localization of Pbx1 transcripts in developing rat embryos. Mech. Dev., 51, 193-198.
41. Sandelin,A. et al. (2004) JASPAR: An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res., 32, D91-D94.
42. Schoenherr,C.J. and Anderson,D.J. (1995) The neuron-restrictive silencer factor (NRSF): A coordinate repressor of multiple neuron-specific genes. Science, 267, 1360-1363.
43. Su,A.I. et al. (2002) Large-scale analysis of the human and mouse transcriptomes. Proc. Natl Acad. Sci. USA, 99, 4465-4470.
44. Taylor,J.A. et al. (1996) Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res., 56, 4108-4110.
45. Thioulouse,J. et al. (1997) ADE-4: A multivariate analysis and graphical display software. Stat. Comput., 7, 75-83.
46. Thomas,D.J. et al. (1993) p53 expression and clinical outcome in prostate cancer. Br. J. Urol., 72, 778-781.
47. Tsai,R.Y. and Reed,R.R. (1997) Cloning and functional characterization of Roaz, a zinc finger protein that interacts with O/E-1 to regulate gene expression: Implications for olfactory neuronal development. J. Neurosci., 17, 4159-4169.
48. Tusher,V.G. et al. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
49. Vandromme,M. et al. (1992) Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J. Cell. Biol., 118, 1489-1500.
50. Varambally,S. et al. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell, 8, 393-406.
51. Wasserman,W.W. and Fickett,J.W. (1998) Identification of regulatory regions which confer muscle-specific gene expression. J. Mol. Biol., 278, 167-181.
52. Wingender,E. et al. (1996) TRANSFAC: A database on transcription factors and their DNA binding sites. Nucleic Acids Res., 24, 238-241.
53. Xiao,D. et al. (2002) GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells. Regul. Pept., 109, 141-148.
54. Xie,X. et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature, 434, 338-345.
55. Zi,X. et al. (2000) Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis, 21, 2225-2235.